CODA Biotherapeutics, Inc.
South San Francisco, CA · Biotech · Defunct
Engineered inhibitory ion channel receptors delivered via AAV gene therapy to primary sensory neurons, activated by oral small-molecule agonists to treat neuropathic pain
codabiotherapeutics.com →- Grants
- $843K
- 2 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 22
- 1 granted · 21 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓202020212022
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Development of a non-opioid chemogenetic therapy for chronic neuropathic pain | $670,308 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of a non-opioid chemogenetic therapy for chronic neuropathic pain | $173,131 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1924 | MOGLING BIO INC | — | — |
| 1925 | Arch Innotek, LLC | — | — |
| 1926 | GENELANCET BIOSCIENCES INC | — | — |
| 1927 | CODA Biotherapeutics, Inc. | — | — |
| 1928 | MOLECULAR EXPRESS, INC. | — | — |
| 1929 | Surf Air Global Ltd | — | $9.9M |
| 1930 | GENOMEDESIGNS LABORATORY, LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Compositions And Methods For Neurological Diseasesgranted
- Crispr Compositions And Methods Of Using The Same For Gene Therapyapplication
- Compositions And Methods For Treating Neurological Disordersapplication
- Genome Editing Vectorsapplication
- Expression Cassettes For Treating Epilepsy And Neuropathic Painapplication
- Adeno-associated Virus Capsids And Engineered Ligand-gated Ion Channels For Focal Epilepsy Treatmentapplication
- Compositions And Methods For Neurological Diseasesapplication
- Adeno-associated Virus Capsids For Hippocampal Neuron Transduction And Focal Epilepsy Treatmentapplication
- Adeno-associated Virus Capsids For Dorsal Root Ganglion And Trigeminal Ganglion Transduction And Treatment Of Neuropathic Painapplication
- Compositions And Methods For Neurological Diseasesapplication
- Compositions And Methods For Neurological Diseasesapplication
- Compositions And Methods For Neurological Diseasesapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.